538034AJ8

• Q2 2026 revenue was $7.7 billion, up 9% year-over-year; operating income was $522 million, up 7%.
• Concerts revenue grew 8% to $6.4 billion; fan attendance hit a record 49 million, up 10%.
• Ticketmaster revenue rose 15% to $852 million, with AOI up 14% and 90 million fee-bearing tickets sold.
• Full-year 2026 capital expenditures projected at $1.1 billion; free cash ended at approximately $2 billion.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• The advisory resolution on executive compensation passed with 187,976,286 votes for, 28,703,894 against, and 2,112,048 abstentions.
• Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal 2026 with 221,753,602 votes for.
• Director election results varied, with Maverick Carter receiving the lowest support (193,131,921 for) and Richard Grenell the highest (216,356,981 for).
• The report was filed under Item 5.07 to disclose the voting results of the annual meeting, with Item 9.01 covering the exhibit of the cover page data file.

5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits

• The notes were issued under a Note Purchase Agreement dated April 30, 2026 and a Master Trust Indenture with a First Supplemental Indenture dated May 8, 2026.
• The notes are secured by mortgages on real property of four venues in the U.S., Netherlands, and Ireland, plus related personal property and revenue assignments.
• The notes are non-recourse to Live Nation Entertainment and its subsidiaries other than the Members and their subsidiaries.
• The issuance closed on May 8, 2026, and the agreements will be filed as exhibits to the company's Form 10-Q for the quarter ending June 30, 2026.

1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits

• Operating loss was $371 million, including a $450 million legal accrual; adjusted operating income (AOI) was $371 million, up 9%.
• Concerts revenue rose 12% to $2.8 billion; Ticketing revenue rose 10% to $765 million; Sponsorship & Advertising revenue rose 20% to $259 million.
• Event-related deferred revenue reached a record $6.6 billion, up 22%; ticketing deferred revenue was $368 million, up 29%.
• Company expects double-digit AOI growth for full-year 2026, with capex of $1.1–1.2 billion and leverage at 3.6x.
• Over 107 million tickets sold to date, up 11%; over 85% of large-venue shows booked for 2026.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Concerts segment AOI rose 30% to $687 million with a record margin of 3.3%; fan attendance grew 5% to 159 million.
• Ticketing revenue grew 3% to $3.1 billion, with AOI up 1% to $1.1 billion; fee-bearing tickets increased 2% to 346 million.
• Sponsorship & Advertising revenue grew 11% to $1.3 billion, with AOI up 11% to $845 million.
• For 2026, the company expects double-digit operating income and AOI growth, with capital expenditures of $1.1–$1.2 billion.
• Q4 2025 revenue was $6.3 billion, up 11%; consolidated operating loss improved to $(142.7) million from $(239.4) million.
• Year-end 2025 event-related deferred revenue was $4 billion, up 21%; over 80% of 2026 large venue shows are booked.
• 2025 free cash flow—adjusted was $1.3 billion, up from $1.15 billion in 2024.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Q3 2025 revenue was $8.5 billion, up 11% year-over-year; operating income rose 24% to $793 million.
• Ticketing AOI grew 21% on a 12% increase in fee-bearing gross transaction value; sponsorship AOI rose 14%.
• Event-related deferred revenue hit a record $3.5 billion, up 37%; Ticketmaster deferred revenue up 30% to $231 million.
• Company expects double-digit AOI growth for full year 2025 and a strong 2026 with double-digit large venue show pipeline growth.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• The new senior secured credit facilities include a $1.3B multicurrency revolving facility, a $400M venue expansion revolving facility, a $700M delayed draw term loan A, and a $1.3B term loan B (fully drawn at closing).
• Proceeds from the term loan B refinanced obligations under the existing credit agreement; other facilities may fund working capital, general corporate purposes, and venue development.
• The revolving facilities and delayed draw term loan A mature October 21, 2030; the term loan B matures October 21, 2032.
• The credit agreement includes a financial covenant requiring a maximum consolidated net debt to EBITDA ratio ranging from 6.75x to 5.25x, with step-downs starting March 31, 2027.

1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits

• Initial purchasers have an option to buy up to an additional $100 million principal amount of notes within 13 days of October 10, 2025.
• Net proceeds, with borrowings under a new credit facility, will fund the redemption of all 5.625% Senior Notes due 2026, repay term loan B and revolving credit facilities, and for general corporate purposes.
• The notes are convertible into cash, common stock, or a combination, at an initial conversion rate of 4.4459 shares per $1,000 principal (about $224.93 per share).
• The company plans to amend or refinance its credit facility to include a $1.3B term loan B, $700M delayed draw term loan A, $1.3B multicurrency revolver, and $400M venue expansion revolver.

1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 3.02 Unregistered Sales of Equity Securities · 8.01 Other Events · 9.01 Financial Statements and Exhibits